Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Jan;63(1):156-7.
doi: 10.1001/archneur.63.1.156.

Analysis of the LRRK2 G2019S mutation in Alzheimer Disease

Cyrus P Zabetian, Chris J Lauricella, Debby W Tsuang, James B Leverenz, Gerard D Schellenberg, Haydeh Payami
Comparative Study

Analysis of the LRRK2 G2019S mutation in Alzheimer Disease

Cyrus P Zabetian et al. Arch Neurol. 2006 Jan.
No abstract available

PubMed Disclaimer

References

    1. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 causeautosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601–607. - PubMed
    1. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. 2004;44:595–600. - PubMed
    1. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. JAMA. 1997;278:1237–1241. - PubMed
    1. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet. 2005;76:672–680. - PMC - PubMed
    1. Kay DM, Zabetian CP, Factor SA, et al. Parkinson’s disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics. Mov Disord. 2005 Oct 25; [Accessed on November 7, 2005]; [Epub ahead of print]. Available at: http://dx.doi.org/10.1002/mds.20751. - DOI - PubMed